{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:14:54Z","timestamp":1772795694997,"version":"3.50.1"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1365,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1111\/j.1365-2133.2011.10637.x","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T12:04:52Z","timestamp":1316520292000},"page":"306-316","source":"Crossref","is-referenced-by-count":15,"title":["Inhibition of benzalkonium chloride-induced skin inflammation in mice by an indol-1-ylpropan-2-one inhibitor of cytosolic phospholipase A2\u03b1"],"prefix":"10.1093","volume":"166","author":[{"given":"K.","family":"Roebrock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bovens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Sunderk\u00f6tter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,12,6]]},"reference":[{"issue":"Suppl.","key":"10.1111\/j.1365-2133.2011.10637.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1194\/jlr.R800033-JLR200","article-title":"Phospholipase A2 structure\/function, mechanism, and signaling","volume":"50","author":"Burke","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nrm2335","article-title":"Lipid signalling in disease","volume":"9","author":"Wymann","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/112_0507","article-title":"Biological effects of lysophospholipids","volume":"160","author":"Rivera","year":"2008","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S1388-1981(02)00152-X","article-title":"Lysophospholipids and their G protein-coupled receptors in inflammation and immunity","volume":"1582","author":"Graler","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/13543770903463905","article-title":"Phospholipase A2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases","volume":"20","author":"Magrioti","year":"2010","journal-title":"Expert Opin Ther Pat"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.bbalip.2006.07.011","article-title":"The phospholipase A2 superfamily and its group numbering system","volume":"1761","author":"Schaloske","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.biocel.2008.07.017","article-title":"Molecules in focus: cytosolic phospholipase A2\u03b1","volume":"41","author":"Niknami","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.bbalip.2006.08.001","article-title":"Biochemical properties and pathophysiological roles of cytosolic phospholipase A2s","volume":"1761","author":"Kita","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.plipres.2006.05.003","article-title":"Properties of the group IV phospholipase A2 family","volume":"45","author":"Ghosh","year":"2006","journal-title":"Prog Lipid Res"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.it.2004.01.006","article-title":"Cytosolic phospholipase A2\u03b1 reigns supreme in arthritis and bone resorption","volume":"25","author":"Bonventre","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/187152306776872488","article-title":"Inhibitors of cytosolic phospholipase A2\u03b1 as potential anti-inflammatory drugs","volume":"5","author":"Lehr","year":"2006","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1016\/j.bmcl.2004.05.024","article-title":"Synthesis and evaluation of substrate-mimicking cytosolic phospholipase A2 inhibitors - reducing the lipophilicity of the arachidonyl chain isostere","volume":"14","author":"Walters","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1021\/jm8009876","article-title":"Reactions of functionalized sulfonamides: application to lowering the lipophilicity of cytosolic phospholipase A2\u03b1 inhibitors","volume":"52","author":"Chen","year":"2009","journal-title":"J Med Chem"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1016\/j.bmc.2009.05.027","article-title":"Benzhydrylquinazolinediones: novel cytosolic phospholipase A2\u03b1 inhibitors with improved physicochemical properties","volume":"17","author":"Kirincich","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1021\/jm061131z","article-title":"Discovery of Ecopladib, an indole inhibitor of cytosolic phospholipase A2\u03b1","volume":"50","author":"Lee","year":"2007","journal-title":"J Med Chem"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1021\/jm701467e","article-title":"Indole cytosolic phospholipase A2\u03b1 inhibitors: discovery and in vitro and in vivo characterization of 4-{3-[5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic acid, efipladib","volume":"51","author":"McKew","year":"2008","journal-title":"J Med Chem"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.bmc.2007.10.060","article-title":"Benzenesulfonamide indole inhibitors of cytosolic phospholipase A2\u03b1: optimization of in vitro potency and rat pharmacokinetics for oral efficacy","volume":"16","author":"Lee","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00011-009-0069-8","article-title":"Cytosolic phospholipase A2\u03b1 inhibitor, pyrroxyphene, displays anti-arthritic and anti-bone destructive action in a murine arthritis model","volume":"59","author":"Tai","year":"2010","journal-title":"Inflamm Res"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-3565(24)29391-5","article-title":"BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid\/water interface and possesses anti-inflammatory activity in skin inflammation models","volume":"298","author":"Burke","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000117816","article-title":"Inhibitory effect of a potent and selective cytosolic phospholipase A2\u03b1 inhibitor RSC-3388 on skin inflammation in mice","volume":"81","author":"Yamamoto","year":"2008","journal-title":"Pharmacology"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB22|cit22","unstructured":"Takagi M Ishimitsu K Nishibe T Oxa(thia)zolidine Derivative and Anti-inflammatory Drug 2001"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1021\/jm1001088","article-title":"1-(5-Carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A2\u03b1 with reduced lipophilicity: synthesis, biological activity, metabolic stability, solubility, bioavailability, and topical in vivo activity","volume":"53","author":"Drews","year":"2010","journal-title":"J Med Chem"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"8298","DOI":"10.1021\/jm101094p","article-title":"1-(5-Carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A2\u03b1: effect of substituents in position 3 of the indole scaffold on inhibitory potency, metabolic stability, solubility, and bioavailability","volume":"53","author":"Bovens","year":"2010","journal-title":"J Med Chem"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1034\/j.1600-0625.2001.100602.x","article-title":"Different pathways leading to cutaneous leukocytoclastic vasculitis in mice","volume":"10","author":"Sunderk\u00f6tter","year":"2001","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/sj.bjp.0705854","article-title":"Anti-inflammatory effects of nitric oxide-releasing hydrocortisone NCX 1022, in a murine model of contact dermatitis","volume":"143","author":"Hyun","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1182\/blood.V82.6.1875.1875","article-title":"MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner","volume":"82","author":"Roth","year":"1993","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB28|cit28","first-page":"191","article-title":"The contact allergens nickel chloride and cobalt chloride directly induce expression of endothelial adhesion molecules","volume":"92","author":"Goebeler","year":"1993","journal-title":"Behring Inst Mitt"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB30|cit30","first-page":"4694","article-title":"A survey of transformation markers in differentiating epidermal cell lines in culture","volume":"40","author":"Yuspa","year":"1980","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s00216-009-2850-5","article-title":"High-performance liquid chromatographic assay with fluorescence detection for the evaluation of inhibitors against fatty acid amide hydrolase","volume":"394","author":"Forster","year":"2009","journal-title":"Anal Bioanal Chem"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ab.2009.12.015","article-title":"High-performance liquid chromatography assay with fluorescence detection for the evaluation of inhibitors against human recombinant monoacylglycerol lipase","volume":"399","author":"Holtfrerich","year":"2010","journal-title":"Anal Biochem"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2133.1985.tb15261.x","article-title":"Topical glucocorticoids and suppression of contact sensitivity. A mouse bioassay of anti-inflammatory effects","volume":"112","author":"Back","year":"1985","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.0022-202x.2001.01626.x","article-title":"Topical peroxisome proliferator activated receptor-\u03b1 activators reduce inflammation in irritant and allergic contact dermatitis models","volume":"118","author":"Sheu","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2133.1997.tb03788.x","article-title":"A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases: in vivo pharmacology","volume":"137","author":"Meingassner","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000236177","article-title":"Expression of the calcium-binding proteins MRP8 and MRP14 by early infiltrating cells in experimental contact dermatitis","volume":"98","author":"Roth","year":"1992","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.5021\/ad.2010.22.3.290","article-title":"Epidermal hyperplasia and elevated HB-EGF are more prominent in retinoid dermatitis compared with irritant contact dermatitis induced by benzalkonium chloride","volume":"22","author":"Lee","year":"2010","journal-title":"Ann Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/1099-1263(200007\/08)20:4<335::AID-JAT698>3.0.CO;2-L","article-title":"Epidermal cytokines in murine cutaneous irritant responses","volume":"20","author":"Effendy","year":"2000","journal-title":"J Appl Toxicol"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/1523-1747.ep12383512","article-title":"Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin","volume":"102","author":"Wilmer","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0300-483X(98)00088-2","article-title":"Selective induction of cell-associated interleukin-1\u03b1 in murine keratinocytes by chemical allergens","volume":"129","author":"Corsini","year":"1998","journal-title":"Toxicology"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.4049\/jimmunol.174.8.5047","article-title":"ERK1\/2 regulates epidermal chemokine expression and skin inflammation","volume":"174","author":"Pastore","year":"2005","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"e1000871","DOI":"10.1371\/journal.ppat.1000871","article-title":"Keratinocytes determine Th1 immunity during early experimental leishmaniasis","volume":"6","author":"Ehrchen","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1600-0625.2008.00786.x","article-title":"The skin: an indispensable barrier","volume":"17","author":"Proksch","year":"2008","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1099-1263(199601)16:1<65::AID-JAT306>3.0.CO;2-T","article-title":"Selective stimulation of cutaneous interleukin 6 expression by skin allergens","volume":"16","author":"Holliday","year":"1996","journal-title":"J Appl Toxicol"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/cmdc.201000473","article-title":"1-(3-Biaryloxy-2-oxopropyl)indol-5-carboxylic acids and related compounds as dual inhibitors of human cytosolic phospholipase A2\u03b1 and fatty acid amide hydrolase","volume":"6","author":"Zahov","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0014-2999(97)85419-2","article-title":"Suppression of cytokine synthesis, integrin expression and chronic inflammation by inhibitors of cytosolic phospholipase A2","volume":"326","author":"Amandi-Burgermeister","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB47|cit47","first-page":"1549","article-title":"Targeting phospholipase A2 for the treatment of inflammatory skin diseases","volume":"2","author":"Burke","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1111\/j.1365-2133.2011.10637.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1742-7843.2007.00130.x","article-title":"Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors","volume":"101","author":"Saario","year":"2007","journal-title":"Basic Clin Pharmacol Toxicol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2011.10637.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2011.10637.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T18:25:16Z","timestamp":1741717516000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/166\/2\/306\/6613644"}},"subtitle":["Inhibition of murine ICD by an inhibitor of cPLA2\u03b1"],"short-title":[],"issued":{"date-parts":[[2011,12,6]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10637.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12,6]]}}}